Emami Paper Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 12, 2025, 2:37 am

Competitors of Emami Paper Mills Ltd

All Competitor Stocks of Emami Paper Mills Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:45 pm

Below is a detailed analysis of the quarterly data for Emami Paper Mills Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 459.76 Cr.. The value appears to be declining and may need further review. It has decreased from 474.95 Cr. (Mar 2025) to 459.76 Cr., marking a decrease of 15.19 Cr..
• For Expenses, as of Jun 2025, the value is 422.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 443.84 Cr. (Mar 2025) to 422.08 Cr., marking a decrease of 21.76 Cr..
• For Operating Profit, as of Jun 2025, the value is 37.68 Cr.. The value appears strong and on an upward trend. It has increased from 31.11 Cr. (Mar 2025) to 37.68 Cr., marking an increase of 6.57 Cr..
• For OPM %, as of Jun 2025, the value is 8.20%. The value appears strong and on an upward trend. It has increased from 6.55% (Mar 2025) to 8.20%, marking an increase of 1.65%.
• For Other Income, as of Jun 2025, the value is 1.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.75 Cr. (Mar 2025) to 1.60 Cr., marking a decrease of 0.15 Cr..
• For Interest, as of Jun 2025, the value is 17.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.80 Cr. (Mar 2025) to 17.05 Cr., marking an increase of 1.25 Cr..
• For Depreciation, as of Jun 2025, the value is 12.88 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.05 Cr. (Mar 2025) to 12.88 Cr., marking a decrease of 0.17 Cr..
• For Profit before tax, as of Jun 2025, the value is 9.35 Cr.. The value appears strong and on an upward trend. It has increased from 4.01 Cr. (Mar 2025) to 9.35 Cr., marking an increase of 5.34 Cr..
• For Tax %, as of Jun 2025, the value is 32.51%. The value appears to be increasing, which may not be favorable. It has increased from 2.24% (Mar 2025) to 32.51%, marking an increase of 30.27%.
• For Net Profit, as of Jun 2025, the value is 6.31 Cr.. The value appears strong and on an upward trend. It has increased from 3.92 Cr. (Mar 2025) to 6.31 Cr., marking an increase of 2.39 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.04. The value appears strong and on an upward trend. It has increased from 0.65 (Mar 2025) to 1.04, marking an increase of 0.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:24 am

Growth

Last Updated: September 5, 2025, 3:30 am

Balance Sheet

Last Updated: October 10, 2025, 1:58 pm

Below is a detailed analysis of the balance sheet data for Emami Paper Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 499.00 Cr.. The value appears to be declining and may need further review. It has decreased from 518.00 Cr. (Mar 2024) to 499.00 Cr., marking a decrease of 19.00 Cr..
• For Borrowings, as of Mar 2025, the value is 941.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 850.00 Cr. (Mar 2024) to 941.00 Cr., marking an increase of 91.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 364.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 334.00 Cr. (Mar 2024) to 364.00 Cr., marking an increase of 30.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,817.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,714.00 Cr. (Mar 2024) to 1,817.00 Cr., marking an increase of 103.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,059.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,085.00 Cr. (Mar 2024) to 1,059.00 Cr., marking a decrease of 26.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 14.00 Cr..
• For Other Assets, as of Mar 2025, the value is 695.00 Cr.. The value appears strong and on an upward trend. It has increased from 574.00 Cr. (Mar 2024) to 695.00 Cr., marking an increase of 121.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,817.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,714.00 Cr. (Mar 2024) to 1,817.00 Cr., marking an increase of 103.00 Cr..

However, the Borrowings (941.00 Cr.) are higher than the Reserves (499.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Emami Paper Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.49. This value is below the healthy minimum of 5. It has decreased from 13.12 (Mar 24) to 3.49, marking a decrease of 9.63.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.32. This value is below the healthy minimum of 5. It has decreased from 10.61 (Mar 24) to 3.32, marking a decrease of 7.29.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.84. This value is within the healthy range. It has decreased from 23.90 (Mar 24) to 12.84, marking a decrease of 11.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.52. It has decreased from 87.70 (Mar 24) to 84.52, marking a decrease of 3.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.52. It has decreased from 87.70 (Mar 24) to 84.52, marking a decrease of 3.18.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.60. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 318.68. It has decreased from 329.56 (Mar 24) to 318.68, marking a decrease of 10.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 24.18. This value is within the healthy range. It has decreased from 39.61 (Mar 24) to 24.18, marking a decrease of 15.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.63. This value is within the healthy range. It has decreased from 29.65 (Mar 24) to 15.63, marking a decrease of 14.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.52. This value is within the healthy range. It has decreased from 18.54 (Mar 24) to 5.52, marking a decrease of 13.02.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.30. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 4.30, marking a decrease of 9.63.
• For PBDIT Margin (%), as of Mar 25, the value is 7.58. This value is below the healthy minimum of 10. It has decreased from 12.02 (Mar 24) to 7.58, marking a decrease of 4.44.
• For PBIT Margin (%), as of Mar 25, the value is 4.90. This value is below the healthy minimum of 10. It has decreased from 8.99 (Mar 24) to 4.90, marking a decrease of 4.09.
• For PBT Margin (%), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 10. It has decreased from 5.62 (Mar 24) to 1.73, marking a decrease of 3.89.
• For Net Profit Margin (%), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 1.34, marking a decrease of 2.88.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.08. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 5.08, marking a decrease of 10.80.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has decreased from 15.32 (Mar 24) to 8.10, marking a decrease of 7.22.
• For Return On Assets (%), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 5. It has decreased from 4.91 (Mar 24) to 1.43, marking a decrease of 3.48.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.61, marking an increase of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.50. This value exceeds the healthy maximum of 1. It has increased from 1.14 (Mar 24) to 1.50, marking an increase of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has increased from 1.08 (Mar 24) to 1.09, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 1.5. It has increased from 1.04 (Mar 24) to 1.05, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.48, marking a decrease of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.26. This value is within the healthy range. It has increased from 4.55 (Mar 24) to 6.26, marking an increase of 1.71.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 37.21. This value is within the healthy range. It has increased from 17.29 (Mar 24) to 37.21, marking an increase of 19.92.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.45. This value is below the healthy minimum of 20. It has increased from 10.08 (Mar 24) to 12.45, marking an increase of 2.37.
• For Earning Retention Ratio (%), as of Mar 25, the value is 62.79. This value is within the healthy range. It has decreased from 82.71 (Mar 24) to 62.79, marking a decrease of 19.92.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.55. This value exceeds the healthy maximum of 70. It has decreased from 89.92 (Mar 24) to 87.55, marking a decrease of 2.37.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.39. This value is below the healthy minimum of 3. It has decreased from 3.56 (Mar 24) to 2.39, marking a decrease of 1.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 24) to 1.43, marking a decrease of 0.82.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,441.44. It has decreased from 1,535.11 (Mar 24) to 1,441.44, marking a decrease of 93.67.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.74, marking a decrease of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from 6.41 (Mar 24) to 9.85, marking an increase of 3.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.34 (Mar 24) to 0.26, marking a decrease of 0.08.
• For Retention Ratios (%), as of Mar 25, the value is 62.78. This value is within the healthy range. It has decreased from 82.70 (Mar 24) to 62.78, marking a decrease of 19.92.
• For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.30 (Mar 24) to 0.98, marking a decrease of 0.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.34 (Mar 24) to 0.26, marking a decrease of 0.08.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.05, marking a decrease of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness